Vector Biolabs
Vector Biolabs, founded in 2004 and based in Malvern, Pennsylvania, is a subsidiary of Fortis Life Sciences that designs and manufactures custom AAV and Adenovirus viral vectors for gene therapy research, serving academic institutions, government agencies, pharmaceutical and biotechnology companies worldwide.
- Company typePrivate
- Founded2004
- HeadquartersMalvern, United States
- Headcount11–50
- GTM typeB2B
- OfferingServices
What Vector Biolabs does
Vector Biolabs is a custom viral vector provider specializing in AAV (Adeno-Associated Virus) and Adenovirus products for gene therapy research, disease modeling, target validation, small molecule screening, and neuroscience applications. Founded in 2004 and headquartered in Malvern, Pennsylvania, the company operates a U.S.-based manufacturing facility and maintains a catalog of more than 62,000 AAV items spanning over 62,000 genes (29,000 human, 27,000 mouse, 6,000 rat) and more than 85,000 adenovirus products, supported by a proprietary library of over 100,000 pre-synthesized cDNA clones. Its technology platform includes custom AAV design and packaging services, dual AAV split-gene vectors for payloads above 4.7kb, shRNA silencing products achieving 70% knockdown efficiency, and a Vector Designer online tool for serotype and promoter selection. All catalog products carry a guaranteed purity above 95%, with custom production delivered in 4-5 weeks and packaging in 2-3 weeks.
The company operates a hybrid revenue model combining direct-to-consumer e-commerce sales of catalog products priced between $475 and $995 per unit with quote-based custom production services for pharmaceutical, biotechnology, academic, and government research buyers. Its customers include the National Institutes of Health, the University of Pennsylvania, the Medical University of South Carolina, and a network of featured international distributors. Vector Biolabs is a subsidiary brand of Fortis Life Sciences, LLC, a privately-held life sciences platform headquartered in Boston, Massachusetts, whose portfolio also includes Bethyl Laboratories, Vector Biosystems, Empirical Bioscience, Arista Biologicals, nanoComposix, and IPOC Holdings. The company employs 11-50 staff, holds no disclosed patents, trademarks, or external awards, and does not publicly report revenue or funding.
Vector Biolabs firmographics
Firmographics- Name
- Vector Biolabs
- Legal name
- Fortis Life Sciences, LLC
- Website
- https://vectorbiolabs.com
- Company type
- Private
- Founded year
- 2004
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Vector Biolabs, founded in 2004 and based in Malvern, Pennsylvania, is a subsidiary of Fortis Life Sciences that designs and manufactures custom AAV and Adenovirus viral vectors for gene therapy research, serving academic institutions, government agencies, pharmaceutical and biotechnology companies worldwide.
- Ownership category
- akta.pro rank
Vector Biolabs industry classification
Industry- Product category
- Viral Vector Manufacturing
- NAICS
- Biological Product (except Diagnostic) Manufacturing (325414), Scientific Research and Development Services (5417)
- SIC
- Services-Commercial Physical & Biological Research (8731), Biological Products, (No Disgnostic Substances) (2836)
- akta.pro primary industry
- Viral Vector Manufacturing Services (AAV, lentiviral, adenoviral) (HLAAAKAD)
- akta.pro secondary industries
- Gene Therapy CDMO (Viral Vector Manufacturing) (HLAGAGAB), Gene Therapy Vector Manufacturing & CDMO Services (HLAAACAJ)
Keywords
Where Vector Biolabs is headquartered
LocationHeadquarters
- HQ city
- Malvern
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
Vector Biolabs business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Supply Chain, Technology or R&D, Infrastructure, Marketing or Sales
Revenue model
- Catalog Product Sales: One-time sales of pre-made AAV and Adenovirus catalog products including control vectors, reporter genes, and shRNA constructs. Products are sold as ready-to-use viral particles with immediate availability for catalog items.
- Custom Production Services: Custom AAV and Adenovirus vector design and production services tailored to specific research needs. Services include custom cloning, plasmid packaging, amplification, and purification. Pricing is quote-based.
- shRNA Screening/Validation Services: Specialized services for gene silencing studies including custom shRNA design, screening, and validation for specific target genes.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Unit Pricing | Pay-as-you-go | AAV Catalog Products - $495 per unit |
| Unit Pricing | Pay-as-you-go | Adenovirus Catalog Products - $475 per unit |
| Unit Pricing | Pay-as-you-go | shRNA Control Products - $475 per unit |
| Unit Pricing | Pay-as-you-go | Gene-specific shRNA Products - $995 per unit |
| Other | Pay-as-you-go | Custom Production Services - Quote-based pricing |
Go-to-market motion1 record
Distribution channels4 records
Marketing channels5 records
Vector Biolabs product offering
Product offeringCore offering
Vector Biolabs designs, manufactures, and supplies custom and catalog viral vectors — primarily AAV (Adeno-Associated Virus) and Adenovirus — for gene therapy, disease modeling, target validation, small molecule screening, and neuroscience research. The company serves academic, government, and pharmaceutical/biotech customers with ready-to-use catalog products and custom production services backed by more than 20 years of plasmid packaging expertise.
Product overview
Vector Biolabs is a custom viral vector provider specializing in AAV (Adeno-Associated Virus) and Adenovirus products for biomedical research and therapeutic development. The company offers a dual approach combining custom production services (AAV Custom Production, AAV Packaging, Adenovirus Construction, Adenovirus Amplification, and shRNA Screening/Validation) with an extensive catalog of ready-to-use products. The product portfolio includes over 62k AAV catalog items covering human, mouse, and rat genes, over 85k adenovirus products, and comprehensive shRNA products for gene silencing. They also provide a Vector Designer tool for custom vector design. Key applications span gene therapy research, disease modeling, target validation, small molecule screening, and neuroscience.
Differentiator
Problem solved
Functional benefit
Products and services
- AAV Custom Production Custom AAV (Adeno-Associated Virus) vector design and construction service that delivers tailored designs for specific research requirements, with 4-5 week turnaround from design to delivery. Targeted at academic, government, and pharmaceutical researchers needing bespoke AAV constructs.
- AAV Packaging (Plasmid Packaging) Plasmid packaging service that produces high-quality, reliable AAV vectors from submitted plasmids in 2-3 weeks, with flexible support for both internally produced and externally produced plasmids. Targeted at researchers with validated plasmid constructs needing AAV production.
- AAV Product Catalog Ready-to-use catalog of AAV vectors covering multiple serotypes and variants including overexpression, shRNA silencing, Cre/FLP recombinases, CRISPR/Cas9, and control/reporter products, priced at $495 per unit. Targeted at researchers needing immediate availability of standard AAV constructs.
- Adenovirus Construction Custom adenovirus construction service using the Ad-HQ system to produce high-yield custom adenovirus vectors with fast turnaround. Targeted at researchers needing tailored adenovirus constructs for gene delivery studies.
- Adenovirus Amplification Adenovirus amplification service that scales up production for in-vivo studies or generates high-titer purified adenovirus preparations. Targeted at researchers needing larger volumes or higher titers for animal studies.
- Adenovirus Product Catalog Catalog of ready-to-use adenovirus vectors including overexpression, calcium indicators (GECI), CRISPR/Cas9, fiber-modified Ad5, iPS stem cell factors, luciferase reporters, and recombinase products, priced at $475 per unit. Targeted at researchers needing standard adenovirus constructs with immediate availability.
- shRNA Screening/Validation Service Specialized service for gene silencing studies using shRNA technology, including custom shRNA design, screening, and validation for specific target genes, delivered via AAV or Adenovirus platforms. Targeted at researchers conducting functional genomics and target validation studies.
- shRNA Product Catalog Catalog of shRNA products for gene silencing available in both AAV and Adenovirus formats with various reporter options including GFP, CFP, YFP, RFP, and mCherry, achieving 70% knockdown efficiency. Control shRNA priced at $475 per unit; gene-specific shRNA priced at $995 per unit.
Quantifiable outcome
- >95% purity guaranteed on all viral vector products
- +1 more outcomes
Companies that use Vector Biolabs
Customer profileNamed customers3 records
Segments3 records
Ideal customer profiles3 records
Vector Biolabs technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature6 records
Vector Biolabs partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- Fortis Life Sciences, LLCcoreVector Biolabs is a subsidiary and brand of Fortis Life Sciences, a privately-held life sciences company headquartered in Boston, Massachusetts. Fortis Life Sciences operates multiple brands including Bethyl Laboratories, Vector Biosystems, Empirical Bioscience, Arista Biologicals, nanoComposix, and IPOC Holdings. Fortis provides the corporate infrastructure, governance, and resources for Vector Biolabs operations.
Scale indicators7 records
Recent moves5 records
Expansion highlights5 records
Vector Biolabs competitors and assessment
Company assessmentBroad incumbents
- Aldevron (Danaher): Aldevron, now part of Danaher, manufactures plasmids, mRNA, and viral vectors including AAV. It is a broader incumbent offering high-quality research- and GMP-grade viral vector services comparable to Vector Biolabs' offerings.
- Thermo Fisher Scientific (Brammer Bio): Through its Brammer Bio viral vector CDMO business, Thermo Fisher is a major incumbent in AAV and other viral vector manufacturing. It represents the largest-scale competitor to Vector Biolabs in custom viral vector services.
- Charles River Laboratories (Vigene Biosciences): Charles River acquired Vigene Biosciences to provide viral vector (AAV, lentivirus) manufacturing services. It competes with Vector Biolabs on custom viral vector production, especially for higher-grade preclinical and clinical work.
- Lonza: Lonza is a global CDMO with significant viral vector and cell & gene therapy manufacturing capacity. It is a broader incumbent that overlaps with Vector Biolabs in custom AAV/adenoviral vector services for biotech customers.
Direct peers
- PackGene Biotech: PackGene Biotech is a CDMO specializing in AAV and lentiviral vector manufacturing with catalog and custom services. It directly competes with Vector Biolabs for AAV gene delivery projects from academic and biotech customers.
- Vigene Biosciences: Vigene Biosciences specializes in AAV and lentiviral vector production services for gene therapy research and preclinical applications. Its service portfolio and target customer base closely align with Vector Biolabs' custom production offering.
- Addgene: Addgene is a major nonprofit plasmid and viral vector repository serving the research community. It competes with Vector Biolabs on catalog breadth for ready-to-use AAV and lentiviral reagents.
- VectorBuilder: VectorBuilder is a direct competitor offering custom AAV, lentiviral, and other viral vector design and manufacturing services with an extensive online catalog — closely mirroring Vector Biolabs' catalog-plus-custom model.
Emerging players
- Cell Biolabs: Cell Biolabs provides viral tools and reagents including adenoviral and lentiviral products for research. It is a comparable niche tools provider serving similar academic and biotech research customers.
- GenScript: GenScript offers gene synthesis, plasmid, and viral vector services including AAV and lentivirus. It overlaps with Vector Biolabs as a one-stop shop for researchers needing genes plus viral delivery.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks6 records
Key highlights7 records
Customer concentration
Vector Biolabs social profiles
Digital presenceVector Biolabs financial estimates
Financial estimateRevenue estimate
Valuation estimate
Vector Biolabs leadership team
Management profileNumber of profiles
Vector Biolabs funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Vector Biolabs M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Vector Biolabs
What does Vector Biolabs do?
Vector Biolabs designs, manufactures, and supplies custom and catalog viral vectors — primarily AAV (Adeno-Associated Virus) and Adenovirus — for gene therapy, disease modeling, target validation, small molecule screening, and neuroscience research. The company serves academic, government, and pharmaceutical/biotech customers with ready-to-use catalog products and custom production services backed by more than 20 years of plasmid packaging expertise.
Is Vector Biolabs a public or private company?
Vector Biolabs is a private company. It is classified as corporate owned and is currently operating.
When was Vector Biolabs founded?
Vector Biolabs was founded in 2004. It employs 11 to 50 people.
Where is Vector Biolabs based?
Vector Biolabs is headquartered in Malvern, United States, in the North America region.
How does Vector Biolabs make money?
Three revenue lines are on record. Catalog Product Sales are the primary driver. The others are custom Production Services and shRNA Screening/Validation Services.
Who are Vector Biolabs's main competitors?
Broad incumbents on record are Aldevron (Danaher), Thermo Fisher Scientific (Brammer Bio), Charles River Laboratories (Vigene Biosciences) and Lonza. Direct peers are PackGene Biotech, Vigene Biosciences, Addgene and VectorBuilder. Emerging players are Cell Biolabs and GenScript.
Does Vector Biolabs have an API?
No public API is recorded for Vector Biolabs.
What industry is Vector Biolabs in?
Vector Biolabs's product category is Viral Vector Manufacturing. Its primary akta.pro industry code is HLAAAKAD, Viral Vector Manufacturing Services (AAV, lentiviral, adenoviral), with a secondary code of HLAGAGAB, Gene Therapy CDMO (Viral Vector Manufacturing). Its NAICS code is 325414 and its SIC code is 8731.